Traditional Chinese medicine composition for treatment of prostatic hyperplasia

Abstract

The invention relates to a traditional Chinese medicine composition for treatment of prostatic hyperplasia, belonging to the field of traditional Chinese medicine. The traditional Chinese medicine composition is characterized by being prepared from the following traditional Chinese medicine raw materials: 4-8 parts of Cimicifuga, 20-40 parts of medicinal cyathula root, 10-20 parts of herba epimedii, 15-25 parts of dodder, 15-25 parts of Eclipta alba, 4-8 parts of leech, 4-8 parts of ground beeltle, 2-5 parts of pangolin, 20-40 parts of talc, 20-40 parts of Lygodium japonicum and 4-8 parts of amber. The traditional Chinese medicine composition has the functions of treating both symptoms and root causes, and combining dredging and tonifying effects, has remarkable treatment effect on prostatic hyperplasia, and has steady curative effect and no toxic or side effect.

Description

Technical field: [0001] The invention relates to a traditional Chinese medicine composition for treating benign prostatic hyperplasia, which belongs to the field of traditional Chinese medicines. Background technique: [0002] Prostatic hyperplasia is a common chronic disease in elderly men. Its incidence rate continues to increase with age, and symptoms also aggravate with age. The main clinical manifestations of benign prostatic hyperplasia are lower urinary tract symptoms such as increased frequency of nocturia, frequent urination, urgency, thinning urine stream, incomplete urination, and inability to hold back urine, often accompanied by other complications such as prostatitis, bladder stones, etc., severe Affect the patient's sleep and daily activities. [0003] Prostatic hyperplasia is the uncontrolled non-malignant proliferation of cells in the gland. These proliferating cells often exist in the surrounding tissues surrounding the urethra. As the hyperplasia continue...

AI Technical Summary

Problems solved by technology

[0004] At present, the treatment of benign prostatic hyperplasia mainly includes drug treatment, surgical treatment and the newly developed minimally invasive treatment, etc., but none of them are satisfactory.